文献速递复苏、休克与脓毒症创伤与烧伤

小鼠肝损伤失控性出血模型中静脉输注合成血小板(SynthoPlate)改善止血

Intravenous administration of synthetic platelets (SynthoPlate) in a mouse liver injury model of uncontrolled hemorrhage improves hemostasis.
PubMed 文献 · J Trauma Acute Care Surg · 2018-01-01
一句话结论小鼠肝撕裂伤模型中,预防性或救治性输注合成血小板SynthoPlate均减少失血量并延迟伤后低血压发生。

研究用小鼠肝撕裂伤失控性腹腔出血模型诱导失血性休克,比较SynthoPlate、对照颗粒和生理盐水在预处理和救治性输注时的止血效果。预处理SynthoPlate组失血量0.68±0.09 g,低于对照颗粒组0.86±0.16 g和生理盐水组0.84±0.13 g(p<0.005);伤后低血压发生时间SynthoPlate组546.7±329.8秒,长于对照颗粒组168.3±106.6秒和生理盐水组137±58秒(p<0.05)。救治性输注SynthoPlate同样减少失血量(0.69±0.18 g vs 对照颗粒0.89±0.17 g vs 生理盐水0.92±0.19 g,p<0.05)。作者认为SynthoPlate可能成为减轻急性严重失血性休克失血量的可行输血产品。

要点

  • 小鼠肝撕裂伤模型中,预处理输注SynthoPlate组失血量0.68±0.09 g,低于对照颗粒组0.86±0.16 g和生理盐水组0.84±0.13 g(p<0.005)。
  • 预处理SynthoPlate组伤后低血压发生时间546.7±329.8秒,长于对照颗粒组168.3±106.6秒和生理盐水组137±58秒(p<0.05)。
  • 肝撕裂伤后救治性输注SynthoPlate组失血量0.69±0.18 g,低于对照颗粒组0.89±0.17 g和生理盐水组0.92±0.19 g(p<0.05)。
  • 作者认为SynthoPlate可能成为急性严重失血性休克中减轻失血量的可行输血产品。

适用人群与场景

  • 小鼠肝撕裂伤失控性腹腔出血模型诱导的失血性休克

处置流程与药物剂量

  • 预处理:肝撕裂伤前输注SynthoPlate、对照颗粒或生理盐水。
  • 救治性输注:肝撕裂伤后输注SynthoPlate、对照颗粒或生理盐水。

研究设计与关键结果

  • 研究类型:小鼠肝撕裂伤失控性腹腔出血模型实验。
  • 预处理输注失血量:对照颗粒组0.86±0.16 g vs 生理盐水组0.84±0.13 g vs SynthoPlate组0.68±0.09 g,p<0.005。
  • 伤后低血压发生时间:对照颗粒组168.3±106.6秒 vs 生理盐水组137±58秒 vs SynthoPlate组546.7±329.8秒,p<0.05。
  • 救治性输注失血量:对照颗粒组0.89±0.17 g vs 生理盐水组0.92±0.19 g vs SynthoPlate组0.69±0.18 g,p<0.05。

证据类型、等级与局限

  • 证据类型:动物实验(小鼠肝损伤模型)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为SynthoPlate可能成为减轻急性严重失血性休克失血量的可行输血产品。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Clinical resuscitative treatment of traumatic hemorrhage involves transfusion of RBC, platelets and plasma in controlled ratios. However, use of such blood components, especially platelets, present many challenges including availability, portability, contamination risks, and short shelf-life, which limit the use of platelet transfusions outside of large trauma centers such as remote civilian hospitals and austere prehospital settings. This has prompted significant research in platelet substitutes that may resolve the above issues while providing platelet-mimetic hemostatic action. In this framework, we have developed a synthetic platelet surrogate, SynthoPlate, by integrative decoration of platelet function mimetic peptides on a biocompatible lipid nanovesicle platform. We have previously demonstrated hemostatic capability of SynthoPlate in correcting tail-bleeding time in thrombocytopenic mice. Building on this, we hypothesized that SynthoPlate transfusion would decrease bleeding in a murine model of acute hemorrhagic shock.

METHODS: A validated model of uncontrolled intraperitoneal hemorrhage, via liver laceration was used to induce hemorrhagic shock in mice. SynthoPlate, control (unmodified) particles, and normal saline were administered as pretreatment and recue infusions to mice undergoing liver laceration and evaluated for hemostatic benefit by determining differences in blood loss and monitoring real-time hemodynamic data.

RESULTS: Pretreatment SynthoPlate transfusion resulted in significant reduction of blood loss following hemorrhage, compared with control particles or normal saline treatment (0.86 ± 0.16 g control particles [CP] vs. 0.84 ± 0.13 g normal saline [NS] vs. 0.68 ± 0.09 g SynthoPlate, p < 0.005). SynthoPlate transfused mice demonstrated improved hemodynamics taking significantly longer to develop post-injury hypotension (168.3 ± 106.6 seconds CP vs. 137 ± 58 seconds NS vs. 546.7 ± 329.8 seconds SynthoPlate, p < 0.05). SynthoPlate infusion following liver laceration, that is, rescue transfusion, also resulted in a significant decrease in blood loss (0.89 ± 0.17 g CP vs. 0.92 ± 0.19 g NS vs. 0.69 ± 0.18 g SynthoPlate, p < 0.05).

CONCLUSION: Transfusion of SynthoPlate particles reduces blood loss in a murine model of liver injury, and SynthoPlates may represent a viable transfusion product for the mitigation of blood loss in acute, severe hemorrhagic shock.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Dyer MR, Hickman D, Luc N, et al. Intravenous administration of synthetic platelets (SynthoPlate) in a mouse liver injury model of uncontrolled hemorrhage improves hemostasis. J Trauma Acute Care Surg. 2018. PMID: 29538234. doi:10.1097/TA.0000000000001893

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。